As of 11:19am ET
| -0.82 / -1.65%|
The 2 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 54.50, with a high estimate of 58.00 and a low estimate of 51.00. The median estimate represents a +11.38% increase from the last price of 48.93.
The current consensus among 2 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.